Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study-Reference-Cited by-同舟云学术

Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study

Published:2021-08 Issue: Volume:229 Page:108786
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

García-Grimshaw Miguel,Ceballos-Liceaga Santa Elizabeth,Hernández-Vanegas Laura E.,Núñez Isaac,Hernández-Valdivia Noé,Carrillo-García Daniel Amado,Michel-Chávez Anaclara,Galnares-Olalde Javier Andrés,Carbajal-Sandoval Guillermo,del Mar Saniger-Alba María,Carrillo-Mezo Roger A.,Fragoso-Saavedra Sergio,Espino-Ojeda Alba,Blaisdell-Vidal Carlos,Mosqueda-Gómez Juan Luis,Sierra-Madero Juan,Pérez-Padilla Rogelio,Alomía-Zegarra José Luis,López-Gatell Hugo,Díaz-Ortega José Luis,Reyes-Terán Gustavo,Arauz Antonio,Valdés-Ferrer Sergio Iván

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N. Engl. J. Med.,2020

2. First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021;Gee;MMWR Morb. Mortal. Wkly Rep.,2021

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Neuroimaging Update: Pathophysiology, Acute Findings, and Post-Acute Developments;Seminars in Ultrasound, CT and MRI;2024-08

2. Group of longitudinal adverse event patterns after the fourth dose of COVID-19 vaccination with a latent class analysis;Frontiers in Public Health;2024-07-30

3. Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions;Journal of Nanobiotechnology;2024-06-02

4. A potent bioreducible ionizable lipid nanoparticle enables siRNA delivery for retinal neovascularization inhibition;European Journal of Pharmaceutics and Biopharmaceutics;2024-06

5. COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment;World Journal of Experimental Medicine;2024-03-20